alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# C_2021266EN.01000701.xml

| 6.7.2021 | EN | Official Journal of the European Union | C 266/7 |
| --- | --- | --- | --- |

6.7.2021

EN

Official Journal of the European Union

C 266/7

---

Prior notification of a concentration

(Case M.10235 – CVC/MeGa Grundbesitz)

(Text with EEA relevance)

(2021/C 266/06)

1.

This notification concerns the following undertakings:

| — | CVC Capital Partners SICAV-FIS S.A. (‘CVC’, Luxembourg) |
| --- | --- |

—

CVC Capital Partners SICAV-FIS S.A. (‘CVC’, Luxembourg)

| — | GABLE Holding GmbH (‘GABLE’, Germany) |
| --- | --- |

—

GABLE Holding GmbH (‘GABLE’, Germany)

| — | MeGa Grundbesitz GmbH (‘MeGa’, Germany) |
| --- | --- |

—

MeGa Grundbesitz GmbH (‘MeGa’, Germany)

CVC acquires within the meaning of Article 3(1)(b) of the Merger Regulation control of the whole of GABLE and MeGa. The concentration is accomplished by way of purchase of shares.

2.

| — | for CVC and its subsidiaries: management of investment funds and platforms. In particular, CVC recently acquired STARK Group A/S, which is a retailer and distributor of predominantly heavy building materials in Germany and the Nordic countries, |
| --- | --- |

—

for CVC and its subsidiaries: management of investment funds and platforms. In particular, CVC recently acquired STARK Group A/S, which is a retailer and distributor of predominantly heavy building materials in Germany and the Nordic countries,

| — | GABLE and MeGa: retail distribution of building materials in Germany. |
| --- | --- |

—

GABLE and MeGa: retail distribution of building materials in Germany.

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.10235 – CVC/MeGa Grundbesitz

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

| European Commission |
| --- |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

1

---
Exhibit 32.1

Informational Addendum to Report on Form 10-Q

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Not Filed Pursuant to the Securities
Exchange Act of 1934

The undersigned Chairman of the Board, President and Chief Executive Officer of OYO Geospace Corporation
does hereby certify as follows:

Solely for the purpose of meeting the requirements of Section 906 of the Sarbanes-Oxley
Act of 2002, and solely to the extent this certification may be applicable to this Report on Form 10-Q, the undersigned hereby certifies that this Report on Form 10-Q fully complies with the requirements of section 13(a) or 15(d) of the Securities
Exchange Act of 1934 and the information contained in this Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of OYO Geospace Corporation.



/s/ Gary D. OwensName:  Gary D. OwensTitle:     Chairman of the Board, Presidentand Chief Executive OfficerFebruary 5, 2010
```

[Federal Register Volume 86, Number 174 (Monday, September 13, 2021)]
[Notices]
[Page 50932]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-19551]

[[Page 50932]]

-----------------------------------------------------------------------

DEPARTMENT OF STATE

[Public Notice: 11530]

Notice of Determinations; Culturally Significant Objects Being 
Imported for Exhibition--Determinations: ``City of Cinema: Paris 1850-
1907'' Exhibition

SUMMARY: Notice is hereby given of the following determinations: I 
hereby determine that certain objects being imported from abroad 
pursuant to agreements with their foreign owners or custodians for 
temporary display in the exhibition ``City of Cinema: Paris 1850-1907'' 
at the Los Angeles County Museum of Art, Los Angeles, California, and 
at possible additional exhibitions or venues yet to be determined, are 
of cultural significance, and, further, that their temporary exhibition 
or display within the United States as aforementioned is in the 
national interest. I have ordered that Public Notice of these 
determinations be published in the Federal Register.

FOR FURTHER INFORMATION CONTACT: Chi D. Tran, Program Administrator, 
Office of the Legal Adviser, U.S. Department of State (telephone: 202-
632-6471; email: [email protected]). The mailing address is U.S. 
Department of State, L/PD, 2200 C Street NW (SA-5), Suite 5H03, 
Washington, DC 20522-0505.

SUPPLEMENTARY INFORMATION: The foregoing determinations were made 
pursuant to the authority vested in me by the Act of October 19, 1965 
(79 Stat. 985; 22 U.S.C. 2459), Executive Order 12047 of March 27, 
1978, the Foreign Affairs Reform and Restructuring Act of 1998 (112 
Stat. 2681, et seq.; 22 U.S.C. 6501 note, et seq.), Delegation of 
Authority No. 234 of October 1, 1999, and Delegation of Authority No. 
236-3 of August 28, 2000.

Matthew R. Lussenhop,
Acting Assistant Secretary, Bureau of Educational and Cultural Affairs, 
Department of State.
[FR Doc. 2021-19551 Filed 9-10-21; 8:45 am]
BILLING CODE 4710-05-P
```
#### All data considered provisional and subject to revision.

      Pool Elevation                    
csv

      Storage                    
csv

      Total Release                    
csv

      Release Volume                    
csv

      Area                    
csv

      Ave Sjc Inflow Volume                    
csv

      Delta Storage                    
csv

#### All data considered provisional and subject to revision.

      Pool Elevation                    
json

      Storage                    
json

      Total Release                    
json

      Release Volume                    
json

      Area                    
json

      Ave Sjc Inflow Volume                    
json

      Delta Storage                    
json
xml version="1.0" encoding="UTF-8"?


C\_2021030EN.01000701.xml


| | | | |
| --- | --- | --- | --- |
| 27.1.2021 | EN | Official Journal of the European Union | C 30/7 |

---

Prior notification of a concentration

(Case M.10112 – CVC/Riverstone Europe)

Candidate case for simplified procedure

(Text with EEA relevance)

(2021/C 30/07)

1.

On 21 January 2021, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 [(1)](#ntr1-C_2021030EN.01000701-E0001).

This notification concerns the following undertakings:

| | |
| --- | --- |
| — | CVC Capital Partners SICAV-FIS S.A. (‘CVC’, Luxembourg), |

| | |
| --- | --- |
| — | RiverStone Barbados Limited (‘Riverstone Europe’, Barbados) |

CVC acquires within the meaning of Article 3(1)(b) of the Merger Regulation control of the whole of Riverstone Europe.

The concentration is accomplished by way of purchase of shares.

2.

The business activities of the undertakings concerned are:

| | |
| --- | --- |
| — | for CVC: CVC and/or its subsidiaries manages investment funds and platforms, |

| | |
| --- | --- |
| — | for Riverstone Europe: Riverstone Europe is active int the management of run-off insurance businesses and portfolios. |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 [(2)](#ntr2-C_2021030EN.01000701-E0002) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.10112 – CVC/Riverstone Europe

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

| |
| --- |
| European Commission |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

---

[(1)](#ntc1-C_2021030EN.01000701-E0001)  [OJ L 24, 29.1.2004, p. 1](http://publications.europa.eu/resource/oj/JOL_2004_024_R_TOC) (the ‘Merger Regulation’).

[(2)](#ntc2-C_2021030EN.01000701-E0002)  [OJ C 366, 14.12.2013, p. 5](http://publications.europa.eu/resource/oj/JOC_2013_366_R_TOC).

---
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

                    The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and                           ( print page 51167)                        the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.                

*Name of Committee:*                         Heart, Lung, and Blood Initial Review Group; Clinical Trials Review Study Section.                    

*Date:*                         October 28-29, 2021.                    

*Time:*                         9:00 a.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, 6705 Rockledge Drive, Bethesda, MD 20817 (Virtual Meeting).                    

*Contact Person:*                         Keary A Cope, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, National Institutes of Health, 6705 Rockledge Drive, Room 209-A, Bethesda, MD 20892-7924, (301) 827-7912,                         *copeka@mail.nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS)

Dated: September 8, 2021.

David W. Freeman,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2021-19759 Filed 9-13-21; 8:45 am]

BILLING CODE 4140-01-P
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
UNAUDITED FINANCIAL STATEMENTS OF THE COMPANY FOR THE THREE MONTHS ENDED MARCH
31, 1998 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          MAR-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               MAR-31-1998
<CASH>                                          19,469
<SECURITIES>                                         0
<RECEIVABLES>                                    5,240
<ALLOWANCES>                                     (386)
<INVENTORY>                                      7,256
<CURRENT-ASSETS>                                32,470
<PP&E>                                           8,894
<DEPRECIATION>                                 (4,774)
<TOTAL-ASSETS>                                  36,637
<CURRENT-LIABILITIES>                            6,863
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            17
<OTHER-SE>                                      29,665
<TOTAL-LIABILITY-AND-EQUITY>                    36,637
<SALES>                                          5,610
<TOTAL-REVENUES>                                 5,610
<CGS>                                            3,871
<TOTAL-COSTS>                                    3,871
<OTHER-EXPENSES>                                 5,215
<LOSS-PROVISION>                                   104
<INTEREST-EXPENSE>                                  23
<INCOME-PRETAX>                                (3,221)
<INCOME-TAX>                                         2
<INCOME-CONTINUING>                            (3,223)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (3,223)
<EPS-PRIMARY>                                   (0.19)
<EPS-DILUTED>                                   (0.19)
        

</TABLE>
# Patent

## Title
Articles utilizing acetal copolymer bonding resins

## Abstract

The results obtained are shown in Table-1. As seen from Table-1, while about 10 percents of the proteins were adsorbed by R-1, the proteins were not adsorbed at all by K-1, K-2, K-3 and K-4. ______________________________________ Recovery Rate (%) Polymer       bovine articles      serum albumin .gamma.-globulin ______________________________________ K-1           100         100 (Example 1) K-2           101         102 Example 2) K-3           100         100 (Example 3) K-4           100         101 (Example 4) R-1            87          90 (Comparative Example 1) ______________________________________

## Background
## Claims

1. Porous polymer particles prepared by the process of polymerizing monomers comprising a compound according to formula (I): ##STR3## wherein R is hydrogen or methyl, n is 0 to 30, m is 0 to 30, with the proviso that m+n>1, formula (I), hydrophilic monomer is between 50:50 and 10:90, and

2. The polymer particles according to claim 1, in which m is 0 and n is a number of from 1 to 10.

3. The polymer particles according to claim 1, in which the hydrophilic monomer is an ester of polyhydric alcohol and a polymerizable monomer having .alpha., .beta.-ethylenic unsaturated bond.

4. The polymer particles according to claim 1, in which the hydrophilic monomer is the one selected from the class consisting of hydroxyethyl (meth)acrylate, hydroxypropyl (meth)acrylate, glycerine (meth)acrylate, pentaerythritol (meth)acrylate, oligoethylene glycol (meth)acrylate and oligopropylene glycol (meth)acrylate.

5. The polymer particles according to claim 1, in which the polymer of the monomer (I) is crosslinked by crosslinking agent.

6. The polymer particles according to claim 1, in which copolymer of the monomer (I) and the hydrophilic monomer is crosslinked by crosslinking agent.

7. The polymer particles according to claim 6, in which the monomer components comprise less than 20 percents by weight of the crosslinking agent based on the total weight of the monomer (I) and the crosslinking agent and weight ratio of the monomer (I) and the crosslinking agent to the hydrophilic monomer is from 50:50 to 10:90.

8. The polymer particles according to claim 1, in which mean grain size is from 1 to 1000.mu.m.
EXHIBIT 6
                                                                      ---------



                        CONSENT OF INDEPENDENT AUDITORS

We hereby consent to (i) the inclusion in Canadian Natural Resources Limited's
Annual Report on Form 40-F for the year ended  December 31, 2006; and (ii) the
incorporation by reference in the registration statement on Form F-9 (File No.
333-138873),  of our audit report dated March 15,  2007,  on the  consolidated
balance sheets of Canadian Natural  Resources  Limited as at December 31, 2006
and 2005, and the consolidated  statements of earnings,  retained earnings and
cash flows for each of years in the three-year  period ended December 31, 2006
and  management's  assessment of the  effectiveness  of internal  control over
financial  reporting and the  effectiveness of internal control over financial
reporting of Canadian  Natural  Resources  Limited as of December 31, 2006. We
also consent to the  reference  to us under the heading  "Experts" in the Form
F-9.


/s/  PricewaterhouseCoopers LLP

Calgary, Alberta
March 28, 2007
## United States Court of Appeals FOR THE EIGHTH CIRCUIT

___________ No. 99-3665

___________ American Premier Underwriters, Inc., * * Appellant, * Appeal from the United States

* District Court for the Western v. * District of Missouri. * Smith, Gill, Fisher & Butts, P.C., * [UNPUBLISHED] * Appellee. *

___________ Submitted: April 13, 2000 Filed: April 19, 2000

___________ Before McMILLIAN, FAGG, and LOKEN, Circuit Judges.

___________ PER CURIAM. AmericanPremier Underwriters, Inc. (APU) appeals the district court's adverse grant of summary judgment in this diversity lawsuit for legal malpractice and fraud. Thedistrict court ruled that APU's claims were barred by the applicable statutes of limitation. Having carefully analyzed the parties' arguments and following de novo review of the record and the questions of state law, we conclude the grant of judgment was proper for the reasons stated by the district court. Because our review involves the application of

state law in a fact-intensive diversity case and the parties' submissions show they are thoroughly familiar with the issues before the court, we conclude that an-2-

extensive discussion would serve no useful precedential purpose. We thus affirm the district court without further discussion. See 8th Cir. R. 47B. A true copy. Attest: CLERK, U.S. COURT OF APPEALS, EIGHTH CIRCUIT.
# L_2014106EN.01004801.xml

| 9.4.2014 | EN | Official Journal of the European Union | L 106/48 |
| --- | --- | --- | --- |

9.4.2014

EN

Official Journal of the European Union

L 106/48

---

Corrigendum to Council Decision 2010/290/EU of 19 January 2010 on the existence of an excessive deficit in Slovakia

(
  Official Journal of the European Union L 125 of 21 May 2010
  )

In the contents and on page 48, in the title:

for:

‘Council Decision of 19 January 2010 on the existence of an excessive deficit in Slovakia (2010/290/EU)’,

read:

‘Council Decision of 2 December 2009 on the existence of an excessive deficit in Slovakia (2010/290/EU)’;

on page 49, concluding formula:

for:

‘Done at Brussels, 19 January 2010.

For the Council

The President

E. SALGADO
  ’,

read:

‘Done at Brussels, 2 December 2009.

For the Council

The President

A. BORG
  ’.

---
Exhibit 23.2

                          INDEPENDENT AUDITORS CONSENT

To Board of Directors
Capital Title Group, Inc.:

We consent to  incorporation  by reference  in the  Registration  Statement  No.
333-66375 on Form S-8 of Capital Title Group,  Inc. of our report dated February
28, 2002,  relating to the  consolidated  balance sheets of Capital Title Group,
Inc.  and  subsidiaries  as of  December  31,  2001 and  2000,  and the  related
consolidated statements of operations,  stockholders' equity, and cash flows for
the years ended December 31, 2001 and 2000, which report appears in the December
31, 2001 annual report on Form 10-K of Capital Title Group, Inc.

                                   /s/ KPMG LLP

Phoenix, Arizona
March 20, 2002
#### All data considered provisional and subject to revision.

      Storage                    
csv

      Inflow                    
csv

      Total Release                    
csv

      Pool Elevation                    
csv

      Delta Storage                    
csv

      Inflow Volume                    
csv

      Release Volume                    
csv

#### All data considered provisional and subject to revision.

      Storage                    
json

      Inflow                    
json

      Total Release                    
json

      Pool Elevation                    
json

      Delta Storage                    
json

      Inflow Volume                    
json

      Release Volume                    
json
Michigan Supreme Court

Lansing, Michigan

Robert P. Young, Jr.

, Chief Justice

Michael F. Cavanagh

Stephen J. Markman

Mary Beth Kelly

Brian K. Zahra

Bridget M. McCormack

David F. Viviano

, Justices

I, Corbin R. Davis, Clerk of the Michigan Supreme Court, certify that the

foregoing is a true and complete copy of the order entered at the direction of the Court.

_________________________________________ Clerk May 1, 2013

t0430 

# Order

May 1, 2013

146251

ANGELA M. SABATOS,

Plaintiff

- Appellee,

v SC: 146251

COA: 302644

Alger CC: 2010

- 005008

- NO

CHERRYWOOD LODGE, INC.,

Defendant

- Appellant.

_________________________________________/

On order of the Court, the application for leave to appeal the August 9, 2012

judgment of the Court of Appeals is considered and, pursuant to MCR 7.302(H)(1), in

lieu of granting leave to appeal, we VACATE the judgment of the Court of Appeals and

we REMAND this case to the Court of Appeals as on reconsideration granted in light of

Hoffner v Lanctoe , 492 Mich 450 (2012).

C AVANAGH , J., would deny leave to appeal.